Syncona Shs GBP ( (GB:SYNC) ) just unveiled an announcement.
Syncona Limited announced the purchase of 150,000 ordinary shares as part of its ongoing share buyback programme, executed through Deutsche Numis. This transaction reduces the company’s total voting shares to 620,245,995, affecting shareholder calculations under the FCA’s rules. The repurchased shares will be held in treasury, aligning with Syncona’s strategic approach to maintain a flexible balance sheet for long-term investment and growth.
More about Syncona Shs GBP
Syncona Limited is a prominent life science investor dedicated to creating, building, and scaling a portfolio of globally leading life science companies. The company focuses on developing transformative treatments for areas with high unmet medical needs, aiming to cultivate a diversified portfolio of 20-25 businesses across various development stages, modalities, and therapeutic areas. By partnering with academic founders and experienced management teams, Syncona strives to deliver impactful treatments to patients, build sustainable companies, and achieve strong risk-adjusted returns for shareholders.
YTD Price Performance: -9.56%
Average Trading Volume: 749,884
Technical Sentiment Consensus Rating: Buy
See more data about SYNC stock on TipRanks’ Stock Analysis page.